AAAAAA

   
Results: 1-13 |
Results: 13
POPULATION PHARMACOKINETIC DETERMINATION OF THE EFFECT OF FOOD ON THEPHARMACOKINETICS OF ORAL 5-FLUOROURACIL (FU) AND ENILURACIL (776C85, 776)
Authors: SHEPARD DR MANI S JANISCH L FLEMING GF SCHILSKY RL RATAIN MJ
Citation: Dr. Shepard et al., POPULATION PHARMACOKINETIC DETERMINATION OF THE EFFECT OF FOOD ON THEPHARMACOKINETICS OF ORAL 5-FLUOROURACIL (FU) AND ENILURACIL (776C85, 776), Annals of oncology, 9, 1998, pp. 600-600
PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER
Authors: FLEMING GF KUGLER JW HOFFMAN PC ANSARI R BITRAN JD KLEPSCH A MALONE D FASANMADE AA RATAIN MJ VOKES EE
Citation: Gf. Fleming et al., PHASE-II TRIAL OF PACLITAXEL AND TOPOTECAN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR SUPPORT IN STAGE-IV BREAST-CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2032-2037
PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF ORAL 9-AMINOCAMPTOTHECIN (NSC-603071)
Authors: MANI S IYER L JANISCH L WANG XL FLEMING GF SCHILSKY RL RATAIN MJ
Citation: S. Mani et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF ORAL 9-AMINOCAMPTOTHECIN (NSC-603071), Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 84-87
RESPONSE OF ALEUKEMIC GRANULOCYTIC SARCOMA TO ALL-TRANS-RETINOIC ACIDPLUS INTERFERON ALFA-2A
Authors: FLEMING GF WAGGONER SE WU S ROTMENSCH J CONLEY BA
Citation: Gf. Fleming et al., RESPONSE OF ALEUKEMIC GRANULOCYTIC SARCOMA TO ALL-TRANS-RETINOIC ACIDPLUS INTERFERON ALFA-2A, Journal of the National Cancer Institute, 89(2), 1997, pp. 172-173
PHASE-I TRIAL AND PHARMACOLOGICAL TRIAL OF SEQUENCES OF PACLITAXEL AND TOPOTECAN IN PREVIOUSLY TREATED OVARIAN EPITHELIAL MALIGNANCIES - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
Authors: OREILLY S FLEMING GF BAKER SD WALCZAK JR BOOKMAN MA MCGUIRE WP SCHILDER RJ ALVAREZ RD ARMSTRONG DK HOROWITZ IR OZOLS RF ROWINSKY EK
Citation: S. Oreilly et al., PHASE-I TRIAL AND PHARMACOLOGICAL TRIAL OF SEQUENCES OF PACLITAXEL AND TOPOTECAN IN PREVIOUSLY TREATED OVARIAN EPITHELIAL MALIGNANCIES - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 15(1), 1997, pp. 177-186
PHASE-I STUDY OF TREATMENT WITH ORAL 13-CIS-RETINOIC ACID, SUBCUTANEOUS INTERFERON ALFA-2A, CISPLATIN, AND 24-HOUR INFUSION 5-FLUOROURACIL LEUCOVORIN/
Authors: FLEMING GF OBRIEN SM HOFFMAN PC VOKES EE VOGELZANG NJ SCHILSKY RL WAGGONER SE RATAIN MJ
Citation: Gf. Fleming et al., PHASE-I STUDY OF TREATMENT WITH ORAL 13-CIS-RETINOIC ACID, SUBCUTANEOUS INTERFERON ALFA-2A, CISPLATIN, AND 24-HOUR INFUSION 5-FLUOROURACIL LEUCOVORIN/, Cancer chemotherapy and pharmacology, 39(3), 1997, pp. 227-232
PHASE-II STUDY OF 96-HR CONTINUOUS-INFUSION ETOPOSIDE AND DOXORUBICINWITH BOLUS CYCLOPHOSPHAMIDE IN REFRACTORY EPITHELIAL OVARIAN-CANCER
Authors: FLEMING GF WAGGONER SE ROTMENSCH J SKOOG LA LANGHAUSER C
Citation: Gf. Fleming et al., PHASE-II STUDY OF 96-HR CONTINUOUS-INFUSION ETOPOSIDE AND DOXORUBICINWITH BOLUS CYCLOPHOSPHAMIDE IN REFRACTORY EPITHELIAL OVARIAN-CANCER, Gynecologic oncology, 65(1), 1997, pp. 42-45
PERIPHERAL-BLOOD MONONUCLEAR CELL DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN VOLUNTEERS WITH AND WITHOUT DIABETES-MELLITUS
Authors: FLEMING GF VOKES EE BUSE JB MICK R DUSHAY J LEVITAN D DOLAN ME
Citation: Gf. Fleming et al., PERIPHERAL-BLOOD MONONUCLEAR CELL DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY IN VOLUNTEERS WITH AND WITHOUT DIABETES-MELLITUS, Cancer chemotherapy and pharmacology, 37(6), 1996, pp. 569-573
ETOPOSIDE COMBINED WITH INTERFERON ALFA-2B - NOVEL EXPLOITATION OF ESTABLISHED ETOPOSIDE PHARMACOKINETICS AND PHARMACODYNAMICS
Authors: MICK R VOKES EE LESTINGI TM GRAYSTERN W FLEMING GF SCHILSKY RL RATAIN MJ
Citation: R. Mick et al., ETOPOSIDE COMBINED WITH INTERFERON ALFA-2B - NOVEL EXPLOITATION OF ESTABLISHED ETOPOSIDE PHARMACOKINETICS AND PHARMACODYNAMICS, Clinical pharmacology and therapeutics, 59(3), 1996, pp. 349-359
PHASE-I STUDY OF ESCALATING DOSES OF MITOXANTRONE AND PACLITAXEL WITHGRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SUPPORT
Authors: FLEMING GF JANISCH L VOGELZANG NJ VOKES EE RATAIN MJ
Citation: Gf. Fleming et al., PHASE-I STUDY OF ESCALATING DOSES OF MITOXANTRONE AND PACLITAXEL WITHGRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR SUPPORT, Cancer, 77(11), 1996, pp. 2308-2312
PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION
Authors: FLEMING GF RATAIN MJ OBRIEN SM SCHILSKY RL HOFFMAN PC RICHARDS JM VOGELZANG NJ KASUNIC DA EARHART RH
Citation: Gf. Fleming et al., PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION, Journal of the National Cancer Institute, 86(5), 1994, pp. 368-372
RESPONSE TO CISPLATIN (P), CONTINUOUS-INFUSION (CIV) 5-FLUOROURACIL (5-FU), AND LEUCOVORIN (L) (PFL) NEOADJUVANT CHEMOTHERAPY IN CARCINOMA OF THE UTERINE CERVIX
Authors: SKOOG LA FLEMING GF WILLIAMS SF QUIET C WAGGONER SE ROTMENSCH J HERBST AL
Citation: La. Skoog et al., RESPONSE TO CISPLATIN (P), CONTINUOUS-INFUSION (CIV) 5-FLUOROURACIL (5-FU), AND LEUCOVORIN (L) (PFL) NEOADJUVANT CHEMOTHERAPY IN CARCINOMA OF THE UTERINE CERVIX, Clinical research, 42(3), 1994, pp. 10000431-10000431
DEDIFFERENTIATED CHORDOMA - RESPONSE TO AGGRESSIVE CHEMOTHERAPY IN 2 CASES
Authors: FLEMING GF HEIMANN PS STEPHENS JK SIMON MA FERGUSON MK BENJAMIN RS SAMUELS BL
Citation: Gf. Fleming et al., DEDIFFERENTIATED CHORDOMA - RESPONSE TO AGGRESSIVE CHEMOTHERAPY IN 2 CASES, Cancer, 72(3), 1993, pp. 714-718
Risultati: 1-13 |